Skip to content

Press Release · Press Releases · Asia-Pacific

Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India

Issued by PR Newswire

Image: PR Newswire

CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026 Study Demonstrated 97.3% Sensitivity and 96.0% Specificity Consistent Performance Across Three Test Batches Integrated Mobile and Cloud Infrastructure Already Deployed in India to Support Anticipated...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories

Press Release

Bitmine Immersion Technologies (BMNR) maakt bekend dat zijn ETH-bezit 6,05 miljoen tokens bedraagt en dat de totale waarde van zijn cryptobezittingen, liquide middelen en verhandelbare effecten 15 miljard dollar bedraagt

Bitmine heeft de afgelopen week 2,04 miljoen aandelen teruggekocht Bitmine heeft tot nu toe in 2026 in totaal 22,9 miljoen aandelen teruggekocht, de grootste aandeleninkoop ooit uitgevoerd door een crypto-treasurybedrijf. Bitmine bezit 4,95% van het totale aanbod van ETH-munten van 122,2...

PR Newswire ·

Press Release

Commvault Announces Second Quarter Fiscal 2027 Financial Results

Subscription revenue1 climbs +21% year over year to $269 million Subscription annualized recurring revenue (ARR)1,2 reaches $1,104 million, up +20% year over year Operating cash flow of $75 million, with free cash flow3 of $71 million TINTON FALLS, N.J. , Oct. 27, 2026 /PRNewswire/ --...

PR Newswire ·